Synthetic vascular grafts fail rapidly in small diameter procedures, such as below-knee grafting, coronary artery bypass, and dialysis access, forcing surgeons to use live vessels harvested from the patient. This results in an additional surgery, increasing costs and recovery time. Furthermore, 20% of patients are unable to provide suitable vessels for use, leaving synthetic grafts as the only option. A long-lasting, safe synthetic graft could eliminate the need for additional surgeries and the accompanying risks.
